Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-03-17
2009-02-03
Minnifield, N. M (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S234100, C424S192100, C424S136100
Reexamination Certificate
active
07485313
ABSTRACT:
Uses of the plasmid-encoded protein pgp3 fromC. trachomatis,serotype D, purified by ion exchange column chromatography and shown to be suitable for quantitative immunoassay on clinical samples in an ELISA format, in methods of eliciting and diagnosing an immune response are described.
REFERENCES:
patent: 4281061 (1981-07-01), Zuk et al.
patent: 4336336 (1982-06-01), Silhavy et al.
patent: 4546083 (1985-10-01), Meyers et al.
patent: 4551433 (1985-11-01), DeBoer
patent: 4588684 (1986-05-01), Brake
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4689406 (1987-08-01), Banks et al.
patent: 4738921 (1988-04-01), Belagaje et al.
patent: 4745056 (1988-05-01), Guterman et al.
patent: 4837148 (1989-06-01), Cregg
patent: 4870008 (1989-09-01), Brake
patent: 4876197 (1989-10-01), Burke et al.
patent: 4880734 (1989-11-01), Burke et al.
patent: 4880911 (1989-11-01), Brewer et al.
patent: 4929555 (1990-05-01), Cregg et al.
patent: 5629167 (1997-05-01), Ratti
patent: 6096519 (2000-08-01), Ratti et al.
patent: 6110705 (2000-08-01), Ratti et al.
patent: 6210968 (2001-04-01), Ratti
patent: 6248563 (2001-06-01), Ratti et al.
patent: 6448234 (2002-09-01), Fling
patent: 6649374 (2003-11-01), Ratti
patent: 7253275 (2007-08-01), Stephens et al.
patent: 7361353 (2008-04-01), Grandi et al.
patent: 7384638 (2008-06-01), Bhatia et al.
patent: 2002/0061848 (2002-05-01), Bhatia et al.
patent: 2003/0170761 (2003-09-01), Stephens et al.
patent: 2004/0053393 (2004-03-01), Ratti
patent: 036259 (1981-09-01), None
patent: 036776 (1981-09-01), None
patent: 060057 (1982-09-01), None
patent: 121775 (1984-10-01), None
patent: 127839 (1984-12-01), None
patent: 136829 (1985-04-01), None
patent: 136907 (1985-04-01), None
patent: 155476 (1985-09-01), None
patent: 164556 (1985-12-01), None
patent: 196056 (1986-10-01), None
patent: 219237 (1987-04-01), None
patent: 293079 (1987-04-01), None
patent: 244042 (1987-11-01), None
patent: 267851 (1988-05-01), None
patent: 284044 (1988-09-01), None
patent: WO 90/14837 (1989-05-01), None
patent: 324274 (1989-07-01), None
patent: 324647 (1989-07-01), None
patent: 329203 (1989-08-01), None
patent: 449681 (1992-08-01), None
patent: 62-96086 (1987-05-01), None
patent: WO 03/049762 (2003-06-01), None
Li et al, 2008, BMC Microbiology, 8:90, 13 pages.
Pal et al Vaccine, 2005, 23:5351-5358.
Pal et al, Vaccine, 2006, 24:766-775.
Comanducci, M. et al., “Diversity of theChlamydia trachomatisCommon Plasmid in Biovars with Different Pathogenicity”,Plasmid, 1990, 23, 149-154.
Comanducci, M. et a., “Expression of a Plasmid Gene ofChlamydia trachomatisEncoding a Novel 28 kDa Antigen”,J. Gen. Microbiology, 1993, 139, 1083-1092.
Tabor, S. and Richardson, “A Bacteriophage T7 RNA Polymerase/Promoter System for Controlled Exclusive Expression of Specific Genes”,PNASUSA, 1985, 82, 1074-1078.
Birkelund, S., “The Molecular Biology and Diagnostics ofChlamydia trachomatis”, Dan. Med. Bull., 1992, 39(4), 304-320.
Harlowe et al., “Antibodies: A Laboratory Manual”, Cold Spring Harbor Laboratory, Cold Spring, New York, pp. 33-34, 564, 1988.
Clark et al., “Enzyme linked Immunsorbent Assay (FUSA): Theoretical and Practical Aspects”, in “Enzyme-Immunoassay”, CRC Press, Inc., pp. 167-179, 1987.
Comanducci, M. et al., “Identification and Characterization of a 28-Kd Protein ofC.trachomatisEncoded by the 7.5-Kb Common Plasmid”, International Symposium on Human Chlamydial infections, Jun. 24-29, 1990; 121-124.
Morrison et al., “Immunology ofChlamydia trachomatisInfections Immunoprotective and Immunopathogenetic Responses”, inSexually Transmitted Diseases, Quinn, T. Ed., Raven Press, Ltd, New York, pp. 57-84, 1992.
Zhang, Y.-X. et al., “Protective Monoclonal Antibodies toChlamydia trachomatisSerovar- and Serogroup-Specific Major Outer Membrane Protein Determinants”,Infect. Immun., 1989, 57(2), 636-638.
Allen, G. et al., “Synthesis and Cloning of a Gene Coding for a Fusion Protein Containing Mouse Epidermal Growth Factor”,J. Biotech., 1987, 5, 93-144.
Amann, E. et al., “Vectors Bearing a Hybridtrp-lacPromoter Useful for Regulated Expression of Cloned Genes inEscherichia coli”, Gene, 1983, 25, 167-178.
Amann, E. And Brosius, “'ATG Vectors∝ for Regulated High-Level Expression of Cloned Genes inEscherichia coli”, Gene, 1985, 40, 183-190.
Augustin, J. and Götz, “Tranformation ofStaphylococcus epidermidisand Other Staphylococcal Species with Plasmid DNA by Electroporation”,FEMS Microbiol. Lett., 1990, 66, 203-208.
Ausubel, ed., “Current Protocols in Molecular Biology”, vol. 2, John Wiley & Sons, 1994, Section 16.8.
Barany, F. And Tomasz, “Genetic Transformation ofStreptococcus pneumoniaeby Heterologous Plasmid Deoxyribonucleic Acid”,J. Bacteriol., 1980, 144, 698-709.
Beach, D. et al., “Functionally Homologous Cell Cycle Control Genes in Budding and Fission Yeast”,Nature, 1982, 300, 706-709.
Birnstiel, M.L. et al., “Transciption Termination and 3' Processing: The End Is In Site!”,Cell, 1985, 41, 349-359.
Boshart, M. et al., “A Very Strong Enhancer is Located Upstream of an Immediate Early Gene of Human Cytomegalovirus”,Cell, 1985, 41, 521-530.
Botstein, D. et al., “Sterile Host Yeasts (SHY): A Eukaryotic System of Biological Containment for Recombinant DNA Experiments”,Gene, 1979, 8, 17-24.
Brake, A. et al., “α-Factor-Directed Synthesis and Secretion of Mature Foreign Proteins inSaccharomyces cerevisiae”, PNASUSA, 1984, 81, 4642-4646.
Butt, T. and Ecker, “Yeast Metallothionein and Applications in Biotechnology”,Microbiol. Rev., 1987, 51(3), 351-364.
Carbonell, L. et al., “Baculovirus-Mediated Expression of Bacterial Genes in Dipteran and Mammalian Cells”,J. Virology, 1985, 56(1), 153-160.
Carbonell, L. et al., “Synthesis of Gene Coding for an Insect-Specific Scorpion Neurotoxin and Attempts to Express It Using Baculovirus Vectors”,Gene, 1988, 73, 409-418.
Cerrone, M. et al., “Cloning and Sequence of the Gene for Heat Shock Protein 60 fromChlamydia trachomatisand Immunological Reactivity of the Protein”,Infect. Immun., 1991, 59(1), 79-90.
Chassy, B. and Flickinger, “Transformation ofLactobacillus caseiby Electroporation”,FEMS Microbiology Letters, 1987, 44, 173-177.
Cohen, J. et al., “Functional Expression in Yeast of theEscherichia coliPlasmis Gene Coding for Chloramphenicol Acetyltransferase”,PNASUSA, 1980, 77(2), 1078-1082.
Cohen, S. et al., “Nonchromosomal Antibiotic Resistance in Bacteria: Genetic Transformation ofEscherichia coliby R-Factor DNA”,PNASUSA, 1972, 69(8), 2110-2114.
Cregg, J. et al., “Pichia pastorisas a Host System for Transformations”,Mol. Cell. Biol., 1985, 5(12), 3376-3385.
Das, S. et al., “Transformation ofKluyveromyces fragilis”, J. Bacteriol., 1984, 158(3), 1165-1167.
Davidow, L. et al., “Integrative Transformation of the YeastYarrowia lipolytica”, Curr. Genet., 1985, 10, 39-48.
Davies, J. and Smith, “Plasmid-Determined Resistance to Antimicrobial Agents”,Ann. Rev. Microbiol., 1978, 32, 469-518.
De Boer, H. et al., “The TAC Promoter: A Functional Hybrid Derived from thetrpandlacPromoters”,PNASUSA, 1983, 80, 21-25.
De Louvencourt, L. et al., “Transformation ofKluyveromyces lactisby Killer Plasmid DNA”,J. Bacteriol., 1983, 154(2), 737-742.
Dijkema, R. et al., “Cloning and Expression of the Chromosomal Immune Interferon Gene of the Rat”,EMBO J., 1985, 4(3), 761-767.
Dower, W. et al., “High Efficiency Transformation ofE. Coliby High Voltage Electroporation”,Nucl. Acids Res., 1988, 16(13), 6127-6145.
Fiedler, S. and Wirth, “Transformation of Bacteria with Plasmid DNA by Electroporation”,Analytical Biochem., 1988, 170, 38-44.
Fraser, M.J
Banner & Witcoff Ltd
Minnifield N. M
Novartis AG
LandOfFree
Recombinant Chlamydia trachomatis pgp3 protein suitable... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant Chlamydia trachomatis pgp3 protein suitable..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant Chlamydia trachomatis pgp3 protein suitable... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4124751